ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 252,64
-1,00%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Dr Reddys Laboratories Ltd (RDY)

  7. Dr Reddys Laboratories Ltd (RDY) Actualités

RDY Dr Reddys Laboratories Ltd

75,21
0,43 (0,58%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Dr Reddys Laboratories Ltd RDY NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,43 0,58% 75,21 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
74,89 74,705 75,43 75,21 74,78
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202414:00BWDr. Reddy's Laboratories Announces the Launch of Doxycycline..
22/3/202412:00GLOBEPharmazz Inc. and Dr. Reddy's Laboratories have entered into..
19/3/202412:00BWDr. Reddy's Laboratories launches Versavo® (bevacizumab) in..
04/3/202412:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202412:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202414:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202412:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202412:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/2/202418:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/2/202416:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/2/202412:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202415:44BWDr. Reddy’s Q3 & 9M FY24 Financial Results
31/1/202413:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202419:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202417:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/1/202416:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202419:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202417:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202414:58DJNIndian Dr. Reddy's in Talks to Buy Haleon's Nicotinell, Sky..
16/1/202412:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202414:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202412:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202412:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202412:00BWDr. Reddy's Announces the Acquisition of MenoLabs®, a..
02/1/202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/1/202412:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202314:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202313:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202312:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/12/202312:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202313:49BWDr. Reddy’s becomes first Indian pharma company to debut on..
12/12/202312:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202312:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/12/202318:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202317:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202313:55DJNCoya Therapeutics Strikes Development, Commercialization..
06/12/202313:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
01/12/202313:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202314:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202313:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202314:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202312:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Dernières Valeurs Consultées

NYSE
RDY
Dr Reddys Laboratories
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés